Format

Send to

Choose Destination
Annu Rev Med. 2016;67:467-86. doi: 10.1146/annurev-med-111314-033712. Epub 2015 Aug 26.

The Past, Present, and Future of Nicotine Addiction Therapy.

Author information

1
Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California 94305; email: JPro@Stanford.edu.
2
Departments of Medicine and Bioengineering & Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, California 94143; email: Neal.Benowitz@ucsf.edu.

Abstract

The tobacco addiction treatment field is progressing through innovations in medication development, a focus on precision medicine, and application of new technologies for delivering support in real time and over time. This article reviews the evidence for combined and extended cessation pharmacotherapy and behavioral strategies including provider advice, individual counseling, group programs, the national quitline, websites and social media, and incentives. Healthcare policies are changing to offer cessation treatment to the broad population of smokers. With knowledge of the past and present, this review anticipates what is likely on the horizon in the clinical and public health effort to address tobacco addiction.

KEYWORDS:

cessation; cigarette; quitline; smoking; tobacco; vape

PMID:
26332005
PMCID:
PMC5117107
DOI:
10.1146/annurev-med-111314-033712
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center